Objective: To evaluate the safety, feasibility and effectiveness of minimally invasive HeartMate 3 LVAD implantation.
Methodology: Forty-seven patients who underwent the HeartMate 3 LVAD implantation by sternotomy and 26 ones who had implantation via minimally invasive method were analyzed. The observation lasted from November 2016 to May 2020.